Reckitt Benckiser Group (LSE:RKT) Total Liabilities : £18,667 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Reckitt Benckiser Group Total Liabilities?

Reckitt Benckiser Group's Total Liabilities for the quarter that ended in Dec. 2023 was £18,667 Mil.

Reckitt Benckiser Group's quarterly Total Liabilities declined from Dec. 2022 (£19,259.00 Mil) to Jun. 2023 (£18,307.00 Mil) but then increased from Jun. 2023 (£18,307.00 Mil) to Dec. 2023 (£18,667.00 Mil).

Reckitt Benckiser Group's annual Total Liabilities declined from Dec. 2021 (£19,493.00 Mil) to Dec. 2022 (£19,259.00 Mil) and declined from Dec. 2022 (£19,259.00 Mil) to Dec. 2023 (£18,667.00 Mil).

Reckitt Benckiser Group Total Liabilities Historical Data

The historical data trend for Reckitt Benckiser Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reckitt Benckiser Group Total Liabilities Chart

Reckitt Benckiser Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

22,732.00

22,133.00

19,493.00

19,259.00

18,667.00

Reckitt Benckiser Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															19,493.00	20,034.00	19,259.00	18,307.00	18,667.00

Reckitt Benckiser Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Reckitt Benckiser Group's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8338	+	(6858	+	3193
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	278)
	=	18,667

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	27136	-	8469
	=	18,667

Reckitt Benckiser Group's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8338	+	(6858	+	3193
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	278)
	=	18,667

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	27136	-	8469
	=	18,667

Reckitt Benckiser Group Total Liabilities Related Terms

Thank you for viewing the detailed overview of Reckitt Benckiser Group's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Reckitt Benckiser Group (LSE:RKT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Reckitt Benckiser Group PLC (LSE:RKT) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

RBGPF:USA RBGLY:USA RB:Mexico RKTl:UK 3RB:Germany

Address

103-105 Bath Road, Slough, Berkshire, GBR, SL1 3UH

Website

https://www.reckitt.com

Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.